Role of Scientific Centre for Expert Evaluation of Medicinal Products in Setting Current Pharmacopoeial Requirements

Abstract

The State Pharmacopoeia is  a  strategic  document  that  stipulates  safety  and quality standards in Russia. Its current progress directly correlates with the functioning of Scientific Centre for Expert Evaluation of Medicinal Products (Ministry of Health of the Russian Federation). Valeria L. Bagirova, Dr.Sci.  (Pharm.),  Professor, Director of Institute of Pharmacopoeia and Medicinal Product Standardisation, follows the key milestones in her exclusive interview. It places special emphasis on harmonisation of Russian provisions with  the  EAEU  Pharmacopoeia and  the  leading  world  pharmacopoeias.  Active  international  cooperation  and over 45%  of  new  monographs  in  edition  XV  confirm  the  dynamic  development of the pharmacopoeia. The interview demonstrates the creation of a common pharmacopoeial area that would provide the patients with high-quality and safe medicinal products.